vs
Side-by-side financial comparison of Carlyle Group Inc. (CG) and Eastman Chemical Company (EMN). Click either name above to swap in a different company.
Eastman Chemical Company is the larger business by last-quarter revenue ($2.0B vs $1.9B, roughly 1.0× Carlyle Group Inc.). Carlyle Group Inc. runs the higher net margin — 18.8% vs 5.3%, a 13.5% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs -13.8%). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs -8.6%).
The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.
Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.
CG vs EMN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $2.0B |
| Net Profit | $358.1M | $105.0M |
| Gross Margin | — | 17.1% |
| Operating Margin | 24.3% | — |
| Net Margin | 18.8% | 5.3% |
| Revenue YoY | 84.1% | -13.8% |
| Net Profit YoY | 69.8% | -42.3% |
| EPS (diluted) | $0.96 | $0.93 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.0B | ||
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $332.7M | $2.2B | ||
| Q2 25 | $1.6B | $2.3B | ||
| Q1 25 | $973.1M | $2.3B | ||
| Q4 24 | $1.0B | $2.2B | ||
| Q3 24 | $2.6B | $2.5B | ||
| Q2 24 | $1.1B | $2.4B |
| Q1 26 | — | $105.0M | ||
| Q4 25 | $358.1M | $105.0M | ||
| Q3 25 | $900.0K | $47.0M | ||
| Q2 25 | $319.7M | $140.0M | ||
| Q1 25 | $130.0M | $182.0M | ||
| Q4 24 | $210.9M | $330.0M | ||
| Q3 24 | $595.7M | $180.0M | ||
| Q2 24 | $148.2M | $230.0M |
| Q1 26 | — | 17.1% | ||
| Q4 25 | — | 17.1% | ||
| Q3 25 | — | 19.7% | ||
| Q2 25 | — | 22.1% | ||
| Q1 25 | — | 24.8% | ||
| Q4 24 | — | 24.7% | ||
| Q3 24 | — | 24.6% | ||
| Q2 24 | — | 25.3% |
| Q1 26 | — | — | ||
| Q4 25 | 24.3% | 0.6% | ||
| Q3 25 | 25.8% | 6.1% | ||
| Q2 25 | 28.0% | 7.4% | ||
| Q1 25 | 17.6% | 11.0% | ||
| Q4 24 | 25.7% | 13.2% | ||
| Q3 24 | 29.9% | 11.4% | ||
| Q2 24 | 20.5% | 12.1% |
| Q1 26 | — | 5.3% | ||
| Q4 25 | 18.8% | 5.3% | ||
| Q3 25 | 0.3% | 2.1% | ||
| Q2 25 | 20.3% | 6.1% | ||
| Q1 25 | 13.4% | 7.9% | ||
| Q4 24 | 20.4% | 14.7% | ||
| Q3 24 | 22.6% | 7.3% | ||
| Q2 24 | 13.9% | 9.7% |
| Q1 26 | — | $0.93 | ||
| Q4 25 | $0.96 | $0.93 | ||
| Q3 25 | $0.00 | $0.40 | ||
| Q2 25 | $0.87 | $1.20 | ||
| Q1 25 | $0.35 | $1.57 | ||
| Q4 24 | $0.56 | $2.81 | ||
| Q3 24 | $1.63 | $1.53 | ||
| Q2 24 | $0.40 | $1.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $566.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.1B | $6.0B |
| Total Assets | $29.1B | $14.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $566.0M | ||
| Q4 25 | $2.0B | $566.0M | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.3B | $837.0M | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $914.8M | — |
| Q1 26 | — | $6.0B | ||
| Q4 25 | $7.1B | $6.0B | ||
| Q3 25 | $6.8B | $5.8B | ||
| Q2 25 | $6.7B | $5.8B | ||
| Q1 25 | $6.4B | $5.9B | ||
| Q4 24 | $6.3B | $5.8B | ||
| Q3 24 | $6.3B | $5.7B | ||
| Q2 24 | $5.7B | $5.6B |
| Q1 26 | — | $14.9B | ||
| Q4 25 | $29.1B | $14.9B | ||
| Q3 25 | $27.1B | $15.0B | ||
| Q2 25 | $25.1B | $15.2B | ||
| Q1 25 | $24.1B | $15.0B | ||
| Q4 24 | $23.1B | $15.2B | ||
| Q3 24 | $22.7B | $15.1B | ||
| Q2 24 | $22.3B | $14.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2B | — |
| Free Cash FlowOCF − Capex | $-1.2B | — |
| FCF MarginFCF / Revenue | -65.1% | — |
| Capex IntensityCapex / Revenue | 2.2% | — |
| Cash ConversionOCF / Net Profit | -3.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.4B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-1.2B | $502.0M | ||
| Q3 25 | $-1.6B | $402.0M | ||
| Q2 25 | $-168.8M | $233.0M | ||
| Q1 25 | $-352.1M | $-167.0M | ||
| Q4 24 | $-352.8M | $540.0M | ||
| Q3 24 | $791.9M | $396.0M | ||
| Q2 24 | $-1.3B | $367.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.2B | $390.0M | ||
| Q3 25 | $-1.6B | $265.0M | ||
| Q2 25 | $-186.3M | $83.0M | ||
| Q1 25 | $-368.8M | $-314.0M | ||
| Q4 24 | $-379.5M | $361.0M | ||
| Q3 24 | $772.8M | $276.0M | ||
| Q2 24 | $-1.3B | $252.0M |
| Q1 26 | — | — | ||
| Q4 25 | -65.1% | 19.8% | ||
| Q3 25 | -475.7% | 12.0% | ||
| Q2 25 | -11.8% | 3.6% | ||
| Q1 25 | -37.9% | -13.7% | ||
| Q4 24 | -36.8% | 16.1% | ||
| Q3 24 | 29.3% | 11.2% | ||
| Q2 24 | -120.4% | 10.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 5.7% | ||
| Q3 25 | 7.0% | 6.2% | ||
| Q2 25 | 1.1% | 6.6% | ||
| Q1 25 | 1.7% | 6.4% | ||
| Q4 24 | 2.6% | 8.0% | ||
| Q3 24 | 0.7% | 4.9% | ||
| Q2 24 | 1.7% | 4.9% |
| Q1 26 | — | — | ||
| Q4 25 | -3.34× | 4.78× | ||
| Q3 25 | -1732.78× | 8.55× | ||
| Q2 25 | -0.53× | 1.66× | ||
| Q1 25 | -2.71× | -0.92× | ||
| Q4 24 | -1.67× | 1.64× | ||
| Q3 24 | 1.33× | 2.20× | ||
| Q2 24 | -8.57× | 1.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CG
| Fund Management Fee | $606.8M | 32% |
| Other | $528.7M | 28% |
| Global Private Equity Segment | $307.3M | 16% |
| Global Credit Segment | $238.0M | 13% |
| Carlyle Alp Invest Segment | $124.6M | 7% |
| Incentive Fee | $55.4M | 3% |
| Fee Related Performance Revenues | $29.2M | 2% |
| Investment Advice | $11.1M | 1% |
EMN
Segment breakdown not available.
